Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc…

Overview of attention for article published in Arthritis Research & Therapy, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

So far, Altmetric has seen 1 news story.

September 13, 2021 3 min read Source/Disclosures Published by: Disclosures: The researchers report funding from Pfizer.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.